Vaxcyte Inc (NASDAQ: PCVX) kicked off on Tuesday, up 0.41% from the previous trading day, before settling in for the closing price of $89.49. Over the past 52 weeks, PCVX has traded in a range of $53.83-$121.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 5.15%. With a float of $120.32 million, this company’s outstanding shares have now reached $124.43 million.
Let’s determine the extent of company efficiency that accounts for 254 employees. In terms of profitability, gross margin is 2.95%, operating margin of -3662.28%, and the pretax margin is -3514.11%.
Vaxcyte Inc (PCVX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vaxcyte Inc is 3.47%, while institutional ownership is 107.36%. The most recent insider transaction that took place on Dec 09 ’24, was worth 218,253. In this transaction CHIEF EXECUTIVE OFFICER of this company sold 2,366 shares at a rate of $92.25, taking the stock ownership to the 136,215 shares. Before that another transaction happened on Dec 05 ’24, when Company’s SVP, GEN COUNSEL & CORP SEC sold 5,000 for $91.49, making the entire transaction worth $457,434. This insider now owns 28,697 shares in total.
Vaxcyte Inc (PCVX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 5.15% per share during the next fiscal year.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Take a look at Vaxcyte Inc’s (PCVX) current performance indicators. Last quarter, stock had a quick ratio of 17.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.68, a number that is poised to hit -1.12 in the next quarter and is forecasted to reach -4.69 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Looking closely at Vaxcyte Inc (NASDAQ: PCVX), its last 5-days average volume was 0.95 million, which is a jump from its year-to-date volume of 0.91 million. As of the previous 9 days, the stock’s Stochastic %D was 28.50%. Additionally, its Average True Range was 3.74.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 38.36%, which indicates a significant decrease from 38.44% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 36.03% in the past 14 days, which was lower than the 61.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $100.65, while its 200-day Moving Average is $84.50. However, in the short run, Vaxcyte Inc’s stock first resistance to watch stands at $92.04. Second resistance stands at $94.21. The third major resistance level sits at $95.49. If the price goes on to break the first support level at $88.59, it is likely to go to the next support level at $87.31. Should the price break the second support level, the third support level stands at $85.14.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
The company with the Market Capitalisation of 11.20 billion has total of 124,637K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -402,270 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -103,120 K.
